Friday, September 6, 2013

FDA to begin fast-tracking even more dangerous Big Pharma drugs


(NaturalNews) The U.S. Food and Drug Administration (FDA) wants to expand the list of drug types eligible for its so-called "Fast Track, Accelerated Approval and Priority Review" process, which is really just a fraudulent shortcut method for drug companies to rush potentially-deadly new drugs to market without appropriate regulatory review. According to reports, the FDA plans to allow certain obesity treatments, antibiotics, and other drugs to be peddled to the masses without first undergoing the normal drug review process, a scheme the agency claims is in the best interests of public health.

The changes, which FDA Commissioner Margaret Hamburg recently proposed to a group of scientific advisers, would fast-track certain untested drugs to market via condensed clinical trials, would have smaller sample sizes and entail shorter duration periods. These same fast-tracked drugs would also receive a special type of priority approval status, allowing them to be prescribed by doctors to so-called "critical need" patients willing to bear the drugs' unknown side effects.

For the rest of the shttp:

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...